Market revenue in 2023 | USD 6,535.7 million |
Market revenue in 2030 | USD 10,873.2 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.03% in 2023. Horizon Databook has segmented the Europe orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
Factors driving the market in the region are presence of large geriatric population in countries such as Germany, France, and Spain. Furthermore, reimbursement provided in majority of the European countries encourages citizens to opt for orthopedic implants as the out - of pocket expenditure is low. This is further anticipated to drive the market over the forecast period.
Furthermore, growing prevalence of osteoporosis and hip fractures due to old age and sport-related injuries in the region is increasing. It has also been analyzed that despite the dominance of the U.S. in the market, Europe has a strong biomaterials sector focused on tissue engineering, as many small and medium tech companies are actively participating in the ongoing research related to innovative biomaterials. This is further anticipated to drive the market in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe orthopedic biomaterials market, including forecasts for subscribers. This continent databook contains high-level insights into Europe orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account